Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
New NIH Technology Enhances Retinal Disease Diagnosis
Researchers at the National Institutes of Health have significantly advanced retinal imaging by integrating artificial intelligence (AI) with adaptive optics (AO) and optical coherence tomography (OCT) technology. This new method, which they call parallel discriminator generative adverbial network (P-GAN), accelerates…
Kiora Receives Key Grant for Clinical Trials in Vision Impairment
Kiora Pharmaceuticals announced that it has secured a grant from the Choroideremia Research Foundation (CRF) to support novel clinical trial endpoints for inherited retinal diseases (IRDs). The grant will fund the validation of the Multiluminence Orientation & Mobility (MLOM™) suite…
DOJ Files Lawsuit Against Regeneron Over Eylea Pricing
The U.S. Department of Justice (DOJ) has initiated a lawsuit against Regeneron Pharmaceuticals under the False Claims Act (FCA), accusing the biotechnology company of fraudulently inflating Medicare reimbursement rates. According to the DOJ, Regeneron submitted false average sales price reports…
Haag-Streit Unveils Retinopathy of Prematurity Simulator
In a significant development aimed at enhancing the training of ophthalmologists, Haag-Streit has unveiled the Eyesi Indirect Ophthalmoscope ROP Simulator. This novel simulator is specifically designed for the training of retinal examinations on preterm infants and the classification of retinopathy…
Innovative VR Solution for Cataract Surgery Training
At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…
The Pineal Gland & The Eye of Horus I OBN
Since Galen, a Greek physician and philosopher, first recorded information on the pineal gland’s significance, it has been the focus of extensive research. Colleagues of Galen held the opinion that the pineal controlled the movement of “psychic pneuma,” an ethereal substance…
Vance Thompson, MD, to Lead ASCRS as New President
The American Society of Cataract and Refractive Surgery (ASCRS) is poised to welcome Vance Thompson, MD, as its new president during the organization’s 2024 annual meeting, which begins this Friday at the Boston Convention and Exhibition Center in Boston. This…
Zeiss Completes Acquisition of DORC
In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…
Qlaris Bio Begins Phase 2 Trials of QLS-111 for Eye Conditions
Qlaris Bio has commenced two critical Phase 2 trials in the United States for its innovative intraocular pressure (IOP)-lowering product, QLS‑111. These masked, randomized clinical trials are designed to investigate the efficacy of QLS‑111 in patients suffering from ocular hypertension…
Melt Pharma Raises $24M for Sedation Tablet
Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…